← Back to Search

Prebiotic

Prebiotic for Healthy Subjects

N/A
Waitlist Available
Led By Raylene Reimer, PhD, RD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks in cross-over design
Awards & highlights

Study Summary

This trial will test the effect of two doses of prebiotic on gut microbiota taxonomy and diversity in order to identify the dosing requirements to positively modulate the gut microbiota.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks in cross-over design
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks in cross-over design for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in baseline fecal bifidobacteria at 4 weeks
Secondary outcome measures
Change in baseline fecal short chain fatty acid concentrations at 4 weeks
Change in baseline gastrointestinal tolerance at 4 weeks
Change in baseline quality of life rating at 4 weeks

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: PrebioticExperimental Treatment1 Intervention
Prebiotic consumed as one daily serving of 7 g in Group 1 and consumed as one daily serving of 2.5-3 g in Group 2.
Group II: ControlPlacebo Group1 Intervention
Isocaloric food without the test prebiotic.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Prebiotic
2016
Completed Phase 2
~720

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
787 Previous Clinical Trials
846,258 Total Patients Enrolled
General MillsIndustry Sponsor
21 Previous Clinical Trials
1,559 Total Patients Enrolled
Raylene Reimer, PhD, RDPrincipal InvestigatorUniversity of Calgary
1 Previous Clinical Trials
53 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the study population include any participants below the age of 30?

"Patients between the ages of 18 to 65 are eligible for this medical trial; however, there are separate trials available catering specifically to those younger and older than this age range. 50 studies focus on participants under 18 years old while 371 exist for seniors over 65."

Answered by AI

To whom is this clinical experiment open for participation?

"This investigation is searching for 50 people aged 18 to 65 who meet the following requirements: BMI between 18.5 and 29.9, stable bodyweight for 3 months preceding the study, healthy male or female regular snackers."

Answered by AI

Are more participants still being invited to join this research?

"The information on clinicaltrials.gov indicates that this medical study is not enrolling patients at present, which was first posted in May 15th 2016 and last updated on May 17th 2022. However, there are 839 other trials actively looking for participants right now."

Answered by AI
~6 spots leftby Apr 2025